Stay updated on Ipilimumab Nivolumab Combo in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab Nivolumab Combo in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab Nivolumab Combo in Melanoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Melanoma is added as a related topic and MedlinePlus Genetics is listed as related topics; the site revision tag has been updated from v3.6.3 to v3.6.4.
    Difference
    0.2%
    Check dated 2026-07-25T10:21:27.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The Conditions section no longer lists Melanoma, and the MedlinePlus related topics section, including the MedlinePlus Genetics link, is removed from the page.
    Difference
    0.2%
    Check dated 2026-07-18T04:42:38.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Adds related topics navigation entries for Melanoma and MedlinePlus Genetics on the study page to link users to related consumer health resources. This change enhances navigational context without altering the study data.
    Difference
    0.2%
    Check dated 2026-07-11T00:52:53.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision: v3.6.3 was added to the page. Items under related topics—Melanoma and MedlinePlus Genetics—and the older revision tag v3.6.2 were removed.
    Difference
    0.2%
    Check dated 2026-07-03T22:45:10.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The page has been updated to revision 3.6.2, replacing the previous 3.6.0 revision. This represents a version update to the page metadata rather than substantive changes to the study content.
    Difference
    0.1%
    Check dated 2026-06-27T01:13:27.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page adds recruitment status indicating that it is no longer seeking participants and introduces new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) along with related topics; the Intervention/Treatment heading is standardized and a new Revision: v3.6.0 tag appears.
    Difference
    0.6%
    Check dated 2026-06-12T16:30:19.000Z thumbnail image

Stay in the know with updates to Ipilimumab Nivolumab Combo in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab Combo in Melanoma Clinical Trial page.